Clinical Trial Update: Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating preemptive therapy or prophylaxis to prevent CMV infection in donor CMV-positive/recipient CMV-negative kidney transplant reci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Kidney Transplantation

Snippet

Sponsor: University of California, San Francisco | Conditions: Cytomegalovirus (CMV), Kidney Transplant; Complications | Phase 3 | Status: RECRUITING